Dulabh Monga is an Oncologist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Monga is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Suzanne Schiffman is a Surgical Oncologist and a General Surgeon in Pittsburgh, Pennsylvania. Dr. Schiffman is rated as an Advanced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Vikram C. Gorantla, MD, specializes in the treatment of sarcoma, breast cancer, gastrointestinal malignancies, and head and neck cancers. Board-certified in internal medicine and medical oncology, he received his medical degree at the University of Texas Southwestern Medical School in Dallas. He completed his internal medicine residency at Washington University, St. Louis, MO, and his hematology/oncology fellowship at UPMC. Dr. Gorantla has a dedicated day seeing breast cancer patients at the Magee-Womens Cancer Progam. He also collaborates with surgical oncologists and gynecologists/oncologists to provide multidisciplinary care to patients. Dr. Gorantla is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Breast Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.

"Kenneth K. Lee, MD, graduated Cum Laude from Harvard University with his BA in Chemistry, and continued on to the University of Chicago where he graduated with his MD in 1981. He also stayed at the University of Chicago for his surgical residency, becoming chief resident in 1987. His certifications include general surgery by the American Board of Surgery and also advanced trauma life support. His honors include being named one of the ""Best Doctors in America"" for 1996 - 2001 and receiving the Henry T. Bahnson Teaching Award in 2002.". Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Familial Pancreatic Cancer, Pancreatic Cancer, Ampullary Cancer, Pancreatectomy, and Small Bowel Resection.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

John C. Rhee, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Rhee is skilled in the management of all forms of cancer and blood diseases, with particular interest in cancers of the gastrointestinal tract and chest, including colorectal, esophageal, gastric, pancreaticobiliary, liver, neuroendocrine, and lung tumors. Dr. Rhee is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Colorectal Cancer, Familial Pancreatic Cancer, Small Cell Lung Cancer (SCLC), Gamma Knife Radiosurgery, and Gastrostomy.

James F. Pingpank Jr., MD, is an associate professor of surgery at the University of Pittsburgh School of Medicine. Dr. Pingpank specializes in regional treatment strategies for advance malignancies of the liver and peritoneal cavity. Dr. Pingpank is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Neuroendocrine Tumor, Liver Embolization, and Hernia Surgery.

Anwaar Saeed, MD, is an Associate Professor of Medicine and the Chief of the Gastrointestinal (GI) Medical Oncology Program at the University of Pittsburgh, University of Pittsburgh Medical Center (UPMC), and UPMC Hillman Cancer Center. She also serves as the Vice Chair of the Colorectal Cancer Committee of the NSABP Foundation. Her research efforts are focused on immune modulatory approaches in patients with gastric & esophageal cancer, colon cancer and hepatocellular carcinoma as well as chemoprevention/ immunoprevention in the high-risk GI population. She has published more than 150 peer reviewed papers, posters and book chapters, and have led more than 40 clinical trials, focused on various immune modulatory regimens including but not limited to immune checkpoint inhibitor combinations with chemotherapy, other checkpoint inhibitors, antibody drug conjugates, bi-specific T cell engagers (BiTE), angiogenesis inhibitors, as well as immunotherapy combinations with regional approaches like stereotactic radiosurgery and intensity-modulated radiation therapy. She currently leads several investigator-initiated trials focused on novel targeted immunotherapy combinations including the ongoing phase I/II CAMILLA multicohort study looking at Cabozantinib plus Durvalumab with or without Tremelimumab in GI malignancies. Results from phase I/II part of the CAMILLA led to the development of the currently ongoing global pivotal trial, STELLAR 303, in patients with previously treated microsatellite stable colorectal cancer. She is also the study chair for a soon to open SWOG/intergroup NCI national trial (S2303) testing a novel chemo-immunotherapy regimen in patients with advanced gastric & esophageal adenocarcinoma. Dr. Saeed is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Stomach Cancer, Cataract Removal, and Gamma Knife Radiosurgery.

Daniel P. Petro, MD, is a medical oncologist and hematologist at Hillman Cancer Center. He treats all cancer types, and has a special interest in a multidisciplinary approach to thoracic malignancies. Dr. Petro is also heavily involved in the research of Phase I trials. Dr. Petro is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, Gamma Knife Radiosurgery, and Awake Craniotomy.

M. Haroon Asif Choudry, MD, is a surgical oncologist at UPMC Hillman Cancer Center, and an associate professor of surgery and surgical oncology at the University of Pittsburgh School of Medicine. Dr. Choudry is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pseudomyxoma Peritonei, Familial Colorectal Cancer, Gastrointestinal Fistula, Hernia Surgery, and Bladder Reconstruction.

Patrick Wagner is a General Surgeon and a Surgical Oncologist in Pittsburgh, Pennsylvania. Dr. Wagner is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Gastrointestinal Fistula, Colostomy, and Ileostomy. Dr. Wagner is currently accepting new patients.

Sricharan Chalikonda is a General Surgeon and a Surgical Oncologist in Pittsburgh, Pennsylvania. Dr. Chalikonda is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pancreatic Cancer, Pseudomyxoma Peritonei, Bile Duct Cysts, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

David Friedland is a Hematologist Oncology specialist and an Oncologist in Pittsburgh, Pennsylvania. Dr. Friedland is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Hongmei Liang, MD, PhD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center at UPMC St. Margaret. Board certified in internal medicine and medical oncology, Dr. Liang received her medical degree from Shandong Medical University, Jinan in Shandong, China and PhD in immunology at the University of Pittsburgh School of Medicine. She completed her residency in internal medicine at Greater Baltimore Medical Center in Maryland and fellowship in hematology and oncology at the University of Pittsburgh Medical Center. Dr. Liang is rated as an Advanced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Childhood Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

David Bartlett is a Surgical Oncologist and a General Surgeon in Monroeville, Pennsylvania. Dr. Bartlett is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pseudomyxoma Peritonei, Colorectal Cancer, Desmoplastic Small Round Cell Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

Christopher R. Marsh, MD, is a medical oncologist and hematologist specializing in the treatment of GI malignancies, including colorectal, pancreatic, and liver cancers. Dr. Marsh is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Vincent Edgar Reyes, Jr., MD, is the chief medical officer of the UPMC Hillman Cancer Center Medical Oncology Network and assistant clinical professor of medicine at the University of Pittsburgh School of Medicine. Dr. Reyes is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Inflammatory Breast Cancer, Small Cell Lung Cancer (SCLC), Colorectal Cancer, and Paget Disease of the Breast.

Robert VanderWeele, MD, MS, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in cytopenias, bleeding and clotting disorders, leukemia, lymphoma, myeloma, GI malignancies, breast cancer, lung cancer, and prostate cancer. Dr. Vanderweele is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Mark Georgiadis is a Hematologist Oncology specialist and a Hematologist in Pittsburgh, Pennsylvania. Dr. Georgiadis is rated as an Advanced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Pleuropulmonary Blastoma, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Non-Hodgkin Lymphoma, and Gastric Lymphoma.

John Lech, DO, is a hematologist/medical oncologist at UPMC Hillman Cancer Center. He specializes in the treatment of gastrointestinal malignancies and peritoneal carcinomas. Dr. Lech is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Pleuropulmonary Blastoma.